SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001451464-19-000003
Filing Date
2019-07-12
Accepted
2019-07-11 21:27:07
Documents
1
Effectiveness Date
2019-07-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8967
  Complete submission text file 0001451464-19-000003.txt   10056
Mailing Address TWO HOUSTON CENTER 909 FANNIN, SUITE 2000 HOUSTON TX 77010
Business Address TWO HOUSTON CENTER 909 FANNIN, SUITE 2000 HOUSTON TX 77010 713-276-7600
Esperance Pharmaceuticals, Inc (Filer) CIK: 0001451464 (see all company filings)

IRS No.: 721607662 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-344116 | Film No.: 19951948